Giulio Superti-Furga

Papers authored by Giulio Superti-Furga

This paper is available in a repository.

2008 Christian Baumgartner, Karoline V. Gleixner, Barbara Peter, Veronika Ferenc, Alexander Gruze, Lily L. Remsing Rix, Keiryn L. Bennett, Puchit Samorapoompichit, Francis Y. Lee, Winfried F. Pickl, Harald Esterbauer, Christian Sillaber, Giulio Superti-Furga

, Peter Valent

Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRα

Download from www.researchgate.net

This paper is made freely available by the publisher.

Oliver Hantschel, Agnes Gstoettenbauer, Jacques Colinge

, Ines Kaupe, Martin Bilban, Thomas R. Burkard, Peter Valent, Giulio Superti-Furga

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

Download from doi.org

Didier Soulat

, Tilmann Bürckstümmer, Sandra Westermayer, Adriana Goncalves, Angela Bauch, Adrijana Stefanovic, Oliver Hantschel, Keiryn L. Bennett, Thomas Decker, Giulio Superti-Furga

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response

Download from emboj.embopress.org

Daniel W. Sherbenou, Oliver J. Hantschel, Lalita Turaga, Ines Kaupe, Ines Kaupe Mag, Stephanie Willis, Thomas Bumm, Richard D. Press, Giulio Superti Furga

, Brian J. Druker, Michael W. Deininger

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia

Download from www.nature.com

Michael Kneidinger, Uwe Schmidt, Uwe Rix, Karoline V. Gleixner, Anja Vales, Christian Baumgartner, Christian Lupinek, Margit Weghofer, Keiryn L. Bennett, Harald Herrmann, Alexandra Schebesta, Wayne R. Thomas, Susanne Vrtala, Rudolf Valenta, Francis Y. Lee and 3 other authors

The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils

Download from ashpublications.org

J. van Eyk, Suresh Mathivanan, Mukhtar Ahmed, Erik Bj�rling, Natalie G. Ahn, Hainard Alexandre, Ramars Amanchy, Philip C. Andrews, Joel S. Bader, Anuradha Nali, Brian M. Balgley, Marcus Bantscheff, Keiryn L. Bennett, Erik Bjorling, Blagoy Blagoev and 168 other authors

Human Proteinpedia enables sharing of human protein data

Download from www.nature.com

G. Superti_Furga, F. Wieland, G. Cesareni, Giulio Superti-Furga

Finally: The digital, democratic age of scientific abstracts

Download from onlinelibrary.wiley.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Oliver D. Hantschel, Florian Grebien, Ines Kaupe, Giulio Superti-Furga

Structural Positioning of the SH2 Domain Is Critical for Bcr-Abl Kinase Activity, Signal Transduction and Oncogenic Transformation

Upload

Oliver Hantschel, Uwe Rix, Giulio Superti-Furga

Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib

Download from www.researchgate.net

This paper was not found in any repository, but could be made available legally by the author.

Ulrike S. Eggert, Giulio Superti-Furga

Drugs in action

Upload

2007 Uwe Rix, Oliver Hantschel, Gerhard Durnberger, Lily L. Remsing Rix, Melanie Planyavsky, Nora V. Fernbach, Ines Kaupe, Keiryn L. Bennett, Peter Valent, Jacques Colinge

, Thomas Kocher, Giulio Superti-Furga

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Download from ashpublications.org

Christian Schuster, Nora Fernbach, Uwe Rix, Giulio Superti-Furga

, Marion Holy, Michael Freissmuth, Harald H. Sitte, Veronika Sexl

Selective serotonin reuptake inhibitors - A new modality for the treatment of lymphoma/leukaemia?

Download from doi.org

Thomas Köcher, Giulio Superti-Furga

Mass spectrometry–based functional proteomics: from molecular machines to protein networks

Download from www.researchgate.net

Oliver Hantschel, Uwe Rix, Uwe Schmidt, Tilmann Bürckstümmer, Michael Kneidinger, Gregor Schütze, Jacques Colinge

, Keiryn L. Bennett, Wilfried Ellmeier, Peter Valent, Giulio Superti-Furga

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib

Download from doi.org

Tilmann Burckstummer, Evren Karayel, Evelyn Dixit, Adriana Goncalves, Christoph Baumann, Gerhard Durnberger, Adrijana Preradovic, Melanie Planyavsky, Jacques Colinge, Keiryn L. Bennett, Giulio Superti-Furga

13 Functional Proteomics of Innate Immunity Signalling

Upload

Horst Feldmann, Thomas C. Marlovits, Giulio Superti-Furga

Vienna special issue: Molecular machines

Download from onlinelibrary.wiley.com

O. Hantschel, M. Brehme, M. Krammer, G. Schuetze, K. Bennett, G. Superti-Furga

Characterization of the Bcr-Abl molecular machine

Upload

J. de las Rivas, Sandra Orchard, Lukasz Salwinski, Samuel Kerrien, Luisa Montecchi-Palazzi, Matthias Oesterheld, Volker Stümpflen, Arnaud Ceol, John Armstrong, Peter Woollard, A. Chartr-Aryamontri, John J. Salama, Susan Moore, Jérôme Wojcik, Gary D. Bader and 28 other authors

The minimum information required for reporting a molecular interaction experiment (MIMIx).

Download from www.nature.com

M. Kneidinger, K. Gleixner, A. Boehm, A. Vales, K. Sonneck, S. Florian, M. Weghofer, C. Lupinek, S. Vrtala, R. Valenta, G. Superti-Furga

, F. Y. Lee, P. Valent

He tyrosine kinase inhibitor dasatinib suppresses IGE-dependent activation and histamine release in basophils

Upload

Oliver Hantschel, Uwe Rix, Tilmann Buerckstuemmer, Uwe Schmidt, Michael Kneidinger, Keiryn L. Bennett, Ines Kaupe, Wilfried Ellmeier, Peter Valent, Giulio Superti-Furga

Systematic profiling and novel targets of the Bcr-Abl kinase inhibitors imatinib, nilotinib and dasatinib

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Giulio Superti-Furga